Lawrence Zeldin

Lawrence Zeldin

Auto-generated profile, based on publicly available information

Lawrence Zeldin

Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2020 in JOR SPINE
Verified
Journal Article
Open access
PDF file
LZLawrence Zeldin
Lawrence Zeldin
GMGrace E. Mosley
Grace E. Mosley
DLDamien Laudier
Damien Laudier
ZGZachary S. Gallate
Zachary S. Gallate
JGJennifer Gansau
Jennifer Gansau
JIJames Iatridis
James Iatridis
Collagen plays a key structural role in both the annulus fibrosus (AF) and nucleus pulposus (NP) of intervertebral disks (IVDs). Changes in collagen content with degeneration suggest a shift from collagen type II to type I within the NP, and the activation of pro‐inflammatory factors is indicative of fibrosis throughout. While IVD degeneration is considered a fibrotic process, an increase in collagen content with degeneration, reflective of fibrosis, has not been demonstrated. Additionally, changes in collagen content and structure in human IVDs with degeneration have not been characterized with high spatial resolution. The collagen content of 23 human lumbar L2/3 or L3/4 IVDs was quantified using second harmonic generation imaging (SHG) and multiple image processing algorithms, and these parameters were correlated with the Rutges histological degeneration grade. In the NP, SHG intensity increased with degeneration grade, suggesting fibrotic collagen deposition. In the AF, the entropy of SHG intensity was reduced with degeneration indicating increased collagen uniformity and suggesting less‐organized lamellar structure. Collagen orientation entropy decreased throughout most IVD regions with increasing degeneration grade, further supporting a loss in collagen structural complexity. Overall, SHG imaging enabled visualization and quantification of IVD collagen content and organization with degeneration. There was an observed shift from an initially complex structure to more uniform structure with loss of microstructural elements and increased NP collagen polarity, suggesting fibrotic remodeling.

1 December 2024 in European Journal of Heart Failure
Verified
Journal Article
Closed access
LZLawrence Zeldin
Lawrence Zeldin
JEJoanna B.S. Eichler
Joanna B.S. Eichler
STSergio Teruya
Sergio Teruya
AWAriel Y. Weinsaft
Ariel Y. Weinsaft
AMAlfonsina Mirabal
Alfonsina Mirabal
MMMathew S. Maurer
Mathew S. Maurer
Aims: Transthyretin cardiomyopathy (ATTR-CM) is characterized by episodes of worsening heart failure (WHF) which can include heart failure (HF) hospitalizations or urgent unplanned visits for administration of intravenous diuretics. WHF characterized by outpatient intensification of oral loop diuretics is common yet its prognostic implications for ATTR-CM patients relative to other WHF events remains unclear. We assessed how WHF characterized by outpatient diuretic intensification (ODI) relates to mortality in this population. Methods and results: This was a retrospective study of ATTR-CM patients presenting to the Columbia University Irving Medical Center. Oral loop diuretic dose was recorded longitudinally. WHF characterized by ODI was defined as a persistent increase in oral loop diuretic dose lasting >1 month. We analysed the all-cause mortality rate after either WHF event (hospitalization or ODI) relative to subjects who had no WHF event. Overall, 303 patients highly treated with tafamidis were included: 152 (50.2%) patients had no WHF events, 35 (11.6%) experienced HF hospitalization, and 145 (47.9%) experienced ODI; 29 (9.6%) patients experienced both WHF events. Patients experiencing ODI had higher rates of subsequent mortality (17.7 per 100 person-years; 95% confidence interval [CI] 13.3–23.7) as did those with a HF hospitalization (29.8 per 100 person-years; 95% CI 17.7–50.3) than patients without WHF events (5.0 per 100 person-years; 95% CI 3.0–8.3) on log-rank test. WHF characterized by ODI was independently associated with mortality in a model adjusting for age, genotype, atrial fibrillation, disease duration, time-varying tafamidis use and National Amyloid Centre (NAC) or Columbia stages. Conclusions: In contemporary patients with ATTR-CM treated with tafamidis, WHF requiring ODI is prognostic of subsequent mortality and is a clinical marker of disease progression.

23 August 2024 in Heart Rhythm
Verified
Journal Article
Closed access
LZLawrence Zeldin
Lawrence Zeldin
JMJonah A. Majumder
Jonah A. Majumder
HYHaiqiu Yang
Haiqiu Yang
HYHirad Yarmohammadi
Hirad Yarmohammadi
ABAngelo Biviano
Angelo Biviano
DSDeepak Saluja
Deepak Saluja

11 October 2023 in Amyloid
Verified
Journal Article
Closed access
LZLawrence Zeldin
Lawrence Zeldin
KWKaran Wats
Karan Wats
KOKathleen M. O’toole
Kathleen M. O’toole
FRFabrizio Remotti
Fabrizio Remotti
MMMathew S. Maurer
Mathew S. Maurer

15 April 2026 in Heart Rhythm
Verified
Journal Article
Closed access
LZLawrence Zeldin
Lawrence Zeldin
JMJonah Majumder
Jonah Majumder
SSSarah Schwartz
Sarah Schwartz
JKJoon Kim
Joon Kim
SGSeth Goldbarg
Seth Goldbarg
DSDeepak Saluja
Deepak Saluja